Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ophtholic Ultra for Ocular Surface Disorders After Cataract Surgery
NCT07868965Phase 4Active, not recruiting
- Sponsor
- Kazakh Eye Research Institute
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 4 trial of Ophtholic Ultra in dry eye disease (DED), sponsored by Kazakh Eye Research Institute. Started Aug 2026; status: active, not recruiting.
02
Drugs
Ophtholic Ultra
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07868965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07868965.